The goal of this clinical research study is to learn if treatment with 2CDA (cladribine) followed by treatment with rituximab can help to control.
Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic reticuloendotheliosis) and B-cell chronic lymphocytic leukemia. Its chemical name is (2CdA). Medical uses · Adverse effects · History · Research directions.
Class: Chemotherapy. Generic Name: Cladribine (KLAD-rah-been), 2CdA, 2- Chlorodeoxyadenosine Trade Name: Leustatin®. For which conditions is this drug. MAxD 3minhighlight DBD4DB42 2CDA 4A5E BB93 BD5ADEE9C8EE Other Sites About Clinical 2CDA. What is a package insert? Cancer Types - C. Curr Opin Investig Drugs. Please don't show me this again. Usually, the drugs work by damaging the RNA or DNA .